Cargando…

A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance

Breast cancer (BC) is a kind of malignant cancer in women, and it has become the most diagnosed cancer worldwide since 2020. Histone methylation is a common biological epigenetic modification mediating varieties of physiological and pathological processes. Lysine-specific demethylase 1 (LSD1), a fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Guan-Jun, Liu, Yan-Jun, Ding, Li-Jian, Tao, Fan, Zhu, Ming-Hui, Shi, Zhen-Yuan, Wen, Juan-Ming, Niu, Meng-Yao, Li, Xiang, Xu, Zhan-Song, Qin, Wan-Jia, Fei, Chen-Jie, Chen, Jiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523086/ https://www.ncbi.nlm.nih.gov/pubmed/36188536 http://dx.doi.org/10.3389/fphar.2022.989575

Ejemplares similares

Biological and therapeutic role of LSD1 in Alzheimer’s diseases
por: Li, Yu, et al.
Publicado: (2022)

LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
por: Noce, Beatrice, et al.
Publicado: (2023)

3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
por: Sarno, Federica, et al.
Publicado: (2018)

Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer
por: Niu, Yajin, et al.
Publicado: (2022)

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation
por: Kraehenmann, Rainer, et al.
Publicado: (2017)

Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
por: Zhao, Jing, et al.
Publicado: (2019)

Role of the 5-HT(2A) Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
por: Holze, Friederike, et al.
Publicado: (2021)

Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia
por: Gao, Tianshu, et al.
Publicado: (2022)

Significant Suppression of Non-small-cell Lung Cancer by Hydrophobic Poly(ester amide) Nanoparticles with High Docetaxel Loading
por: Chen, Xing, et al.
Publicado: (2018)

LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice
por: Alper, Kenneth, et al.
Publicado: (2018)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
por: Mao, Long-fei, et al.
Publicado: (2020)

Phosphatase and Tensin Homology Deleted on Chromosome 10 Inhibitors Promote Neural Stem Cell Proliferation and Differentiation
por: Liu, Xiaojiang, et al.
Publicado: (2022)

Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration
por: Qin, Ting-ting, et al.
Publicado: (2022)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
por: Li, Xiang, et al.
Publicado: (2023)

The Natural Polypeptides as Significant Elastase Inhibitors
por: Ahmad, Shabir, et al.
Publicado: (2020)

Preclinical Pharmacokinetics, Tissue Distribution, and Primary Safety Evaluation of Indo5, a Novel Selective Inhibitor of c-Met and Trks
por: Luo, Teng, et al.
Publicado: (2021)

Inositol-Requiring Enzyme 1 Alpha Endoribonuclease Specific Inhibitor STF-083010 Alleviates Carbon Tetrachloride Induced Liver Injury and Liver Fibrosis in Mice
por: Chen, Qian-Qian, et al.
Publicado: (2018)

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis
por: Chen, Dinghua, et al.
Publicado: (2023)

Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome
por: Zhou, Xiu, et al.
Publicado: (2019)

Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors
por: Zhang, Yuejuan, et al.
Publicado: (2022)

A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia
por: Liao, Dan, et al.
Publicado: (2019)

Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy
por: Srikanth, Sandhya, et al.
Publicado: (2016)

Therapeutic effect and mechanism of Anemarrhenae Rhizoma on Alzheimer’s disease based on multi-platform metabolomics analyses
por: Wang, Hui, et al.
Publicado: (2022)

Natural products as LSD1 inhibitors for cancer therapy
por: Fang, Yuan, et al.
Publicado: (2021)

The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study
por: Li, Zhong-Bin, et al.
Publicado: (2021)

LSD1: biologic roles and therapeutic targeting
por: Maiques-Diaz, Alba, et al.
Publicado: (2016)

Pharmacological Inhibition of LSD1 for Cancer Treatment
por: Yang, Guan-Jun, et al.
Publicado: (2018)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2021)

Diagnostic and therapeutic value of P2Y12R in epilepsy
por: Chen, Xiang, et al.
Publicado: (2023)

Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
por: Shi, Ying, et al.
Publicado: (2018)

Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
por: Xu, Jin-Feng, et al.
Publicado: (2021)

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
por: Xu, Jie, et al.
Publicado: (2020)

Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance
por: Kang, Fanhua, et al.
Publicado: (2023)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
por: Chen, Xiaojie, et al.
Publicado: (2022)

A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1
por: Prusevich, Polina, et al.
Publicado: (2014)

Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023)

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Structure–Activity Relationship and In Silico Evaluation of cis- and trans-PCPA-Derived Inhibitors of LSD1 and LSD2
por: Niwa, Hideaki, et al.
Publicado: (2022)

A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
por: Botti, Valeria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ihqtvn1gjutj30oj55mc56rftc